Medical device mergers on pause (EvaluateMedTech)
2019 was an average year for medtech M&A. 2020, not so much.
Thanks to Thermo Fisher Scientific and Invitae, two groups brave enough to push ahead with multibillion-dollar acquisitions during a pandemic, the total value of medical device M&A announced in the first half of 2020 nudged over $15bn. This is still a distressingly low figure, however the real shock is not the value of the deals announced, but of those that have closed.
The medtech deals completed so far in 2020 have a total value of less than $2bn. This is despite mer...
